Endoluxe, Mayo Clinic partner on AI research

Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.

Through the agreement, Mayo Clinic will use the Endoluxe Visualization System, a tool that utilizes AI to provide clinicians with data during surgical procedures, and in turn Endoluxe will use the insights gained to advance development of its platform, according to a Dec. 5 Endoluxe news release. 

Endoluxe designs its video platforms to be vendor agnostic.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars